NRG1 and hypertensive disorder: In support of this, GGF2 treatment altered several genes consistent with effects of the nonsteroidal anti-inflammatory drug clopidogrel (11 genes, p = 4.6 × 10−7, Z = 3.302, Table 3) and the hypertension drug enalapril (13 genes, p = 9.3 × 10−11, Z = 3.073, Table 3).